These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24939816)

  • 21. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
    Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J
    Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.
    Wang W; Ren F; Wu Q; Jiang D; Li H; Shi H
    Oncol Rep; 2014 Nov; 32(5):2127-33. PubMed ID: 25176450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
    Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
    Konno R
    Hum Cell; 2001 Dec; 14(4):261-6. PubMed ID: 11925926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.
    Creighton CJ; Fountain MD; Yu Z; Nagaraja AK; Zhu H; Khan M; Olokpa E; Zariff A; Gunaratne PH; Matzuk MM; Anderson ML
    Cancer Res; 2010 Mar; 70(5):1906-15. PubMed ID: 20179198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A microRNA survival signature (MiSS) for advanced ovarian cancer.
    Shih KK; Qin LX; Tanner EJ; Zhou Q; Bisogna M; Dao F; Olvera N; Viale A; Barakat RR; Levine DA
    Gynecol Oncol; 2011 Jun; 121(3):444-50. PubMed ID: 21354599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
    Hsu CY; Bristow R; Cha MS; Wang BG; Ho CL; Kurman RJ; Wang TL; Shih IeM
    Clin Cancer Res; 2004 Oct; 10(19):6432-6. PubMed ID: 15475429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
    Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of microRNA-21 in ovarian epithelial carcinoma and its clinical significance].
    Lou YH; Yang XS; Wang FL; Qian JH; Huang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):608-10, 613. PubMed ID: 20335152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas.
    De Meyer T; Bijsmans IT; Van de Vijver KK; Bekaert S; Oosting J; Van Criekinge W; van Engeland M; Sieben NL
    J Pathol; 2009 Jan; 217(1):14-20. PubMed ID: 18991331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
    Kuznetsov VA; Tang Z; Ivshina AV
    BMC Genomics; 2017 Oct; 18(Suppl 6):692. PubMed ID: 28984201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.
    Canet B; Pons C; Espinosa I; Prat J
    Hum Pathol; 2011 Jun; 42(6):833-9. PubMed ID: 21208644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.
    Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT
    Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and Investigation of an LINC00284-Associated Regulatory Network in Serous Ovarian Carcinoma.
    Wang S; Zhang L; Tao L; Pang L; Fu R; Fu Y; Liang W; Ding Y; Jia W
    Dis Markers; 2020; 2020():9696285. PubMed ID: 32076467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.